Krystal Biotech buy Cantor Fitzgerald
Start price
29.08.24
/
50%
€182.70
Target price
29.08.25
-
Performance (%)
-31.50%
End price
30.08.25
€125.15
Summary
This prediction ended on 30.08.25 with a price of €125.15. The BUY prediction by Cantor_Fitzgerald for Krystal Biotech performed very badly with a performance of -31.50%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 0.139% | 0.139% | 27.418% |
| iShares Core DAX® | -1.665% | -10.870% | -0.717% |
| iShares Nasdaq 100 | -3.766% | -5.147% | 13.412% |
| iShares Nikkei 225® | -2.803% | -11.299% | 25.461% |
| iShares S&P 500 | -2.299% | -4.801% | 8.938% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€178.75
20.02.25
20.02.25
€205.35
20.02.26
20.02.26
22.52%
21.02.26
21.02.26
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
13.12.23
13.12.23
€166.84
13.12.24
13.12.24
47.38%
14.12.24
14.12.24
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
75.83%
08.11.24
08.11.24